Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma - Wikidata - wikimedia - TriplyDB

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

http://www.wikidata.org/entity/Q58362747

about

Recurrent, bilateral, and metastatic pheochromocytoma in a young patient with Beckwith-Wiedemann syndrome: A genetic link?In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma.Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas.Neurofibromatosis-related phaeochromocytoma: two cases with large tumours and elevated plasma methoxytyramine.Urinary Bladder Paragangliomas: How Immunohistochemistry Can Assist to Identify Patients With SDHB Germline and Somatic Mutations.Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma.SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.Review of Pediatric Pheochromocytoma and Paraganglioma.Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience.Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma.New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).Predictors of outcome in phaeochromocytomas and paragangliomas.Establishment and evaluation of a novel biomarker-based nomogram for malignant phaeochromocytomas and paragangliomas.Cardiac paraganglioma with a novel germline mutation of succinate dehydrogenase gene D.Pathology and genetics of phaeochromocytoma and paraganglioma.Max Schottelius: Pioneer in Pheochromocytoma.Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations Oncometabolite induced primary cilia loss in pheochromocytoma Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine

P2860

Q33665069-35F3D5E7-AA15-4AE5-9AF2-BBE16B0AFD06 Q34636519-939DBCA4-5375-4052-8F45-7E132F3B5DFE Q35203161-9F59E4C6-BCE8-4A05-B7B2-46344EA97B81 Q35942899-FD16EFDE-4D3E-441E-9F27-162FDB8F6336 Q36163643-0CEB367E-B363-43DA-9996-89B4219BBF36 Q36228294-1C7366B7-A033-4A09-A7A9-F3DEB2D039A7 Q37269244-0C3C8B88-50EB-415C-8C00-3DC6667667DA Q39191471-B4123979-CD66-4100-8A50-DCDFB503319B Q40999640-6D0B8943-C17F-41A1-AA2A-08B871A55CBA Q41225447-193C64FC-CFEA-42DF-A4A1-0EED9536F8DD Q43969223-F58CA5F0-DCCC-46EA-8043-C985952BD325 Q47934716-F0C03060-59D9-43E6-964B-39A84C96A496 Q48221255-787875B6-F731-4B12-83AE-D45A7E731018 Q48246997-EBB62FBC-BC45-4A51-9DB5-F535F0DAC622 Q48249097-F1256A4C-C5F7-4415-92BF-9071C330E7D1 Q49607371-B1265BD9-6487-41CE-BB35-EBF75EC7CB73 Q49852319-0D4BE52F-5AF8-4727-AE4E-A65DD264BBE6 Q52741451-CCEC2878-0DBE-423E-8C9B-F1CF37F00204 Q57165237-0D328320-7BDD-45FC-A2CD-69E18A7043EC Q57793471-51F9AFDE-20E1-485C-B298-CCED60DA720B Q57822415-B6B6AD27-42CA-43CC-9E36-2F172AE868E2 Q58700167-918973DE-0607-4AB9-98B4-AA774521CE71

P2860

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

http://www.wikidata.org/entity/Q58362747

description

im Februar 2014 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 06 May 2014

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2014

@uk

name

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

@en

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

@nl

type

label

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

@en

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

@nl

prefLabel

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

@en

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

@nl

P1433

Q58362747-0B7431F5-A318-4E11-B231-96A27E36DB01

P1476

Q58362747-A7A4F1BE-520E-4A42-9A9C-E9FE5672D17D

P2093

Q58362747-03F07875-0893-43D1-AC32-3D9D0DC99AFD

Q58362747-28956936-9B87-4734-8F7D-0DF7A40F6105

Q58362747-58ADF450-2DCC-40F0-992D-285FD9923475

Q58362747-6581D7F5-0CCC-43F7-B98B-25ECBD505A3F

Q58362747-C7B55BC0-DA61-40AA-B897-FA93C5A3C936

Q58362747-C89A2C11-7CAE-45A4-81D6-6C45E43F900B

Q58362747-D199B09A-4F02-46E8-B136-3F5D971CFC65

Q58362747-D875042D-C108-47B7-AA22-AD0D0A4779AE

Q58362747-E2E44A97-969F-48AB-96B2-E732CD20D721

Q58362747-EB770AD1-43EB-4154-9654-020B5ED8EC19

P304

Q58362747-E3B3943E-47B3-47CC-A66A-5A6A2CFAE8AF

P31

Q58362747-0052989A-4498-454A-8F05-8FD9509CF788

P356

Q58362747-E3A33305-F1BE-47B8-8FE2-4828DF4AA86F

P433

Q58362747-B4E47D80-DF44-4577-9EBD-4AD3EC86781A

P478

Q58362747-78C5E2C2-0BC5-4DD1-B694-1BE2A0E0B2D9

P50

Q58362747-8E39EC85-1320-4C7B-BF90-2B1F6F2F2E36

Q58362747-A0F18F5E-ABC8-4B0F-A765-4BC510EEF3F0

P577

Q58362747-5778ABB8-C688-4187-9AD3-480C5B127147

P698

Q58362747-DCD175CA-1C8A-4CFC-A5CD-19D9BCA09733

P921

Q58362747-89145FFE-2480-4D13-8D94-1804C78B7100

Q58362747-B8174068-3D79-454A-A19A-B397A8698125

P356

P1433

Endocrine-related cancer

P1476

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

@en

P2093

Akiyo Tanabe

http://www.w3.org/2001/XMLSchema#string

Eiji Itagaki

http://www.w3.org/2001/XMLSchema#string

Itaru Kimura

http://www.w3.org/2001/XMLSchema#string

Mitsuhide Naruse

http://www.w3.org/2001/XMLSchema#string

Nae Takizawa

http://www.w3.org/2001/XMLSchema#string

Narihiko Kakoi

http://www.w3.org/2001/XMLSchema#string

Noriko Kimura

http://www.w3.org/2001/XMLSchema#string

Phaeochromocytoma Study Group in Japan

http://www.w3.org/2001/XMLSchema#string

Ryoichi Takayanagi

http://www.w3.org/2001/XMLSchema#string

Takayuki Katabami

http://www.w3.org/2001/XMLSchema#string

P304

405-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/ERC-13-0494

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24521857

http://www.w3.org/2001/XMLSchema#string

P921

cancer research